ArticleFrontiers in psychiatry2026
Case Report: Panic attack induced by albendazole in a post-PCI patient.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Albendazole is a widely used broad-spectrum anthelmintic whose recognized neuropsychiatric adverse effects are largely limited to encephalitis and demyelinating encephalopathy. Panic attack has not been previously reported as an adverse reaction to albendazole. Case presentation: A 59-year-old Chinese man with recent percutaneous coronary intervention for coronary artery disease was prescribed albendazole (600 mg/day for 7 days) for an incidentally detected Conclusions: This case suggests that albendazole can probably induce acute panic attacks, expanding its neuropsychiatric adverse effect spectrum. In patients with heightened central nervous system vulnerability-such as those recovering from major cardiovascular procedures-the risk may be increased. For non-urgent anthelmintic indications in such patients, deferring treatment until clinical stabilization may be prudent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.